Skip to content
NewsBlazeIN – Lifestyle
Author:
Cyllene Therapeutics
Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
July 23, 2026
Cyllene Therapeutics (formerly known as EG 427) Raises €33 Million Series C Financing to Advance Clinical Development of EG110A and Pipeline Expansion
July 7, 2026